2025 – Clinical Trial Results

Dr. Hofmann and Dr. Gibson discuss HELP-MI SWEDEHEART trial

September 5, 2025

Disclosures: TBD

Dr. Adam Castano and Dr. C. Michael Gibson discuss: ACT-EARLY, a Phase 3 Study – Clinical Trial Results

May 12, 2025

Disclosures: Sponsored by BridgeBio Pharma, Inc

#ACC2025 Antithrmbotic / Antiplatelet Wrap Up:

April 11, 2025

Dr. Bhatt and I discuss ticagrelor reversal using bentracimab from the REVERSE-IT trial, as well as comparable efficacy and safety […]

Dr. Xiaojie Xie and Dr. C. Michael Gibson discuss: Efficacy And Safety Of SHR-1918, An Angiopoietin-like 3 Monoclonal Antibody, In Combination With Lipid-lowering Therapy In Patients With Suboptimally Controlled Hyperlipidemia: A Multicenter, Randomized, Double Blind, Placebo-controlled Phase 2 Trial

March 31, 2025

Disclosures: TBD

Dr. Michael J. Koren and Dr. C Michael Gibson discuss: Efficacy And Safety Of Azd0780, An Oral Small Molecule Pcsk9 Inhibitor For Treatment Of Hypercholesterolemia: Results From A Ph2b Randomized Placebo-controlled Clinical Trial

March 31, 2025

Disclosures: TBD

Dr. Marco G. Mennuni and Dr. C. Michael Gibson discuss: Alternative Antithrombotic Pathways In Acute Myocardial Infarction With Large Thrombus Burden: A Randomized Trial ARISE-ARMYDA 7

March 31, 2025

Disclosures: TBD

Dr. Jian-An Wang and I discuss: Comparison Of Angiography-derived Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention Strategies: The FLAVOUR II Trial

March 31, 2025

Disclosures: TBD

Dr. Marc Humbert and Dr. C. Michael Gibson Discuss: Efficacy And Safety Of Sotatercept In High-Risk Patients With Pulmonary Arterial Hypertension: Results From ZENITH Phase 3 Trial

March 31, 2025

Disclosures: TBD

Dr. Kausik K. Ray and Dr. C. Michael Gibson Discuss: Effect Of Solbinsiran, A Small Interfering RNA Targeting ANGPTL3, On Biomarkers Of Major Adverse Cardiovascular Events In Adults With Mixed Dyslipidemia: A Randomized Phase 2 Trial

March 31, 2025

Disclosures: TBD

Dr. Katja Vu Bartholdy and Dr. Gibson discuss: Effects Of Dapagliflozin On Echocardiographic Measures Of Cardiac Structure And Function In Patients With Chronic Kidney Disease: The DECODE-CKD Trial

March 31, 2025

Disclosures: TBD